Course Description
Gynecologic pathology is a large sub-specialty area covering numerous sites, diseases and cancers. Due to the breadth of this field, many nuanced details regarding classification of disease, intra-operative consultation, newly described tests and staging of gynecologic cancer remain unknown to many surgical pathologists. Most practicing surgical pathologists see ample amounts of gynecologic surgical pathology on a routine basis including biopsy material, specimens for intra-operative consultation and cancer resections which require laboratory work-up and assessment of important staging pathologic variables. Such complexity makes it essential that some of the intricacies of this field be discussed. The aim of this course will be to discuss some of the more difficult specimens encountered within this discipline, as well as new clinical tests that have become available. In addition, portions of the course will address chronically difficult staging issues that are commonly encountered.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
- List and describe common problems encountered in diagnosing, grading and staging endometrial adenocarcinoma
- List and describe common problems encountered in diagnosing and grading cervical carcinoma
- Describe histologic and molecular features of uterine mesenchymal tumors
- Describe the approach to diagnosis in abnormal products of conception specimens
Topics :
- Uterine Smooth Muscle Tumors
- Endometrial Low-Grade Carcinoma and Mimic
- Endometrial High-Grade Carcinoma and Mimics
- Endocervical Neoplasia
- Uterine Mesenchymal Tumors Other Than Smooth Muscle
- Endometrial Carcinoma Staging Issues
- Cervical Cancer Staging Issues
- Gestational Trophoblastic Diseases
- Panel Discussion – Endometrial Cancer Typing
- Panel Discussion – Endocervical Adenocarcinoma Typing and Staging
- Panel Discussion – Staging Issues in Endometrial Carcinoma
- Panel Discussion – Abnormal Products of Conception and Mesenchymal Tumors
Original release date: April 29, 2020
